Gasiflatyl 40 mg 30 tablets
Composition:
Active ingredient: Simethicone (activated dimethicone) — 40 mg per tablet.
Excipients with known effect: Sucrose — 240.74 mg, Glucose monohydrate — 300 mg.
Description:
Gasiflatyl is an anti-flatulent medication used to relieve symptoms caused by excess gas in the gastrointestinal tract. Its active ingredient, simethicone, works by reducing the surface tension of gas bubbles, causing them to collapse and be eliminated more easily. The medicine acts locally in the gut and is not absorbed into the bloodstream. It helps relieve bloating, abdominal pressure, and discomfort associated with gas buildup.
Indications for Use:
Symptomatic relief of gas in adults and adolescents from 12 years of age.
Dosage and Method of Administration:
Adults and adolescents (12+ years): 2 chewable tablets (80 mg simethicone) three times daily after main meals.
Maximum daily dose: 12 tablets (480 mg simethicone).
Pediatric population: This dosage form is not suitable for children; other formulations are available on the Egyptian market.
Administration method: Oral use. Chew the tablets thoroughly before swallowing.
If symptoms worsen or persist after 10 days, clinical reassessment is advised.
Contraindications:
Hypersensitivity to simethicone or any excipient.
Suspected or known intestinal perforation or obstruction.
Precautions:
If symptoms persist after 10 days or if prolonged constipation occurs, medical evaluation is necessary.
Warnings about excipients:
This medicine contains sucrose and glucose. Patients with hereditary fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine.
May damage the teeth.
Side Effects:
Frequency not precisely known.
Possible side effects:
Gastrointestinal: moderate transient constipation, nausea, belching (as part of gas elimination).
Immune system: hypersensitivity reactions such as rash, itching, facial or tongue swelling, difficulty breathing.
Pregnancy and Breastfeeding:
Simethicone is not absorbed in the digestive tract.
Pregnancy: No data in pregnant women, but systemic effects are unlikely.
Breastfeeding: Not known if excreted in breast milk, but unlikely due to lack of maternal absorption.
Storage Conditions:
Store in a dry place at a temperature not exceeding 30 °C. Shelf life: 2 years.
Packaging:
Carton box contain strips, each containing 10 tablets, a package leaflet.